Patient-derived tumor models of esophageal cancer.

Abstract Tumor models are powerful tools to plan preclinical therapeutic strategies that cannot be conducted on humans. Recently, patient-derived tumor models such as patient-derived xenograft (PDX) and/or patient-derived organoid (PDO), are widely used to investigate the antitumor effects of various drugs, because those tumors resemble original tumors at the […]

View Original Source at Patient-derived tumor models of esophageal cancer.